New Evidence Available

Updated Recommendation

A new evidence synthesis was published:2025, Medical eligibility criteria for contraceptive use, 6th ed.

View latest version (2025)

Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use
Year of Publication2015
Issuing InstitutionWorld Health Organization

Recommendation

Retired

Women using Non-nucleoside/ nucleotide reverse transcriptase inhibitors (NNRTIs) containing either efavirenz or nevirapine can generally use combined oral contraceptive (pill) (COCs), combined injectable contraceptives (CICs), combined contraceptive patches and rings, progestogen-only pill(POPs), progestogen-only injectable(POIs) (DMPA and NET-EN), and levonorgestrel (LNG) and etonogestrel(ETG) implants